Skip to main content
Top
Published in: Clinical and Translational Oncology 3/2018

01-03-2018 | Research Article

Failure modes and effects analysis of total skin electron irradiation technique

Authors: B. Ibanez-Rosello, J. A. Bautista, J. Bonaque, J. Perez-Calatayud, A. Gonzalez-Sanchis, J. Lopez-Torrecilla, L. Brualla-Gonzalez, T. Garcia-Hernandez, A. Vicedo-Gonzalez, D. Granero, A. Serrano, B. Borderia, C. Solera, J. Rosello

Published in: Clinical and Translational Oncology | Issue 3/2018

Login to get access

Abstract

Purpose

Total skin electron irradiation (TSEI) is a radiotherapy technique which consists of an homogeneous body surface irradiation by electrons. This treatment requires very strict technical and dosimetric conditions, requiring the implementation of multiple controls. Recently, the Task Group 100 report of the AAPM has recommended adapting the quality assurance program of the facility to the risks of their processes.

Materials and methods

A multidisciplinary team evaluated the potential failure modes (FMs) of every process step, regardless of the management tools applied in the installation. For every FM, occurrence (O), severity (S) and detectability (D) by consensus was evaluated, which resulted in the risk priority number (RPN), which permitted the ranking of the FMs. Subsequently, all the management tools used, related to the TSEI process, were examined and the FMs were reevaluated, to analyze the effectiveness of these tools and to propose new management tools to cover the greater risk FMs.

Results

361 FMs were identified, 103 of which had RPN ≥80, initially, and 41 had S ≥ 8. Taking this into account the quality management tools FMs were reevaluated and only 30 FMs had RPN ≥80. The study of these 30 FMs emphasized that the FMs that involved greater risk were related to the diffuser screen placement and the patient’s position during treatment.

Conclusions

The quality assurance program of the facility has been adapted to the risk of this treatment process, following the guidelines proposed by the TG-100. However, clinical experience continually reveals new FMs, so the need for periodic risk analysis is required.
Literature
1.
go back to reference Karzmack C, Anderson J, Buffa A, Fessenden P, Khan F, Svensson G, et al. The report of Task Group No. 23 of the AAPM: Total Skin Electron Therapy: Technique and dosimetry. AAPM; 1988. Karzmack C, Anderson J, Buffa A, Fessenden P, Khan F, Svensson G, et al. The report of Task Group No. 23 of the AAPM: Total Skin Electron Therapy: Technique and dosimetry. AAPM; 1988.
2.
go back to reference Mazzeo E, Rubino L, Buglione M, Antognoni P, Magrini SM, Bertoni F, et al. The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: principles and indications. Rep Pract Oncol Radiother. 2013;19:77–91.CrossRefPubMedPubMedCentral Mazzeo E, Rubino L, Buglione M, Antognoni P, Magrini SM, Bertoni F, et al. The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: principles and indications. Rep Pract Oncol Radiother. 2013;19:77–91.CrossRefPubMedPubMedCentral
3.
go back to reference Diamantopoulos S, Platoni K, Dilvoi M, Nazos I, Geropantas K, Maravelis G, et al. Clinical implementation of total skin electron beam (TSEB) therapy: a review of the relevant literatura. Phys Med. 2011;27:62–8.CrossRefPubMed Diamantopoulos S, Platoni K, Dilvoi M, Nazos I, Geropantas K, Maravelis G, et al. Clinical implementation of total skin electron beam (TSEB) therapy: a review of the relevant literatura. Phys Med. 2011;27:62–8.CrossRefPubMed
4.
go back to reference Podgorsak EB. Radiation oncology physics: a handbook for teachers and students. Viennas: IAEA; 2005. Podgorsak EB. Radiation oncology physics: a handbook for teachers and students. Viennas: IAEA; 2005.
5.
go back to reference Bao Q, Hrycushko BA, Dugas JP, Hager FH, Solberg TD. A technique for pediatric total skin electron irradiation. Radiat Oncol. 2012;20:40–7.CrossRef Bao Q, Hrycushko BA, Dugas JP, Hager FH, Solberg TD. A technique for pediatric total skin electron irradiation. Radiat Oncol. 2012;20:40–7.CrossRef
6.
go back to reference Evans MD, Hudon C, Podgorsak EB, Freeman CR. Institutional experience with a rotational total skin electron irradiation (RTSEI) technique-A three decade review (1981-2012). Rep Pract Oncol Radiother. 2013;19:120–34.CrossRefPubMedPubMedCentral Evans MD, Hudon C, Podgorsak EB, Freeman CR. Institutional experience with a rotational total skin electron irradiation (RTSEI) technique-A three decade review (1981-2012). Rep Pract Oncol Radiother. 2013;19:120–34.CrossRefPubMedPubMedCentral
7.
go back to reference Kim TH, Pla C, Pla M, Podgorsak EB. Clinical aspects of a rotational total skin electron irradiation. Br J Radiol. 1984;57:501–6.CrossRefPubMed Kim TH, Pla C, Pla M, Podgorsak EB. Clinical aspects of a rotational total skin electron irradiation. Br J Radiol. 1984;57:501–6.CrossRefPubMed
8.
go back to reference Karzmark CJ, Loevinger R, Steele RE, Weissbluth M. A technique for large-field, superficial electron therapy. Radiology. 1960;74:633–44.CrossRefPubMed Karzmark CJ, Loevinger R, Steele RE, Weissbluth M. A technique for large-field, superficial electron therapy. Radiology. 1960;74:633–44.CrossRefPubMed
9.
go back to reference Carrasco E. Ph.D. thesis. Universidad de Sevilla, Sevilla, 2007. Carrasco E. Ph.D. thesis. Universidad de Sevilla, Sevilla, 2007.
10.
go back to reference Kutcher GJ, Coia L, Gillin M, Hanson WF, Leibel S, Morton RJ, et al. Comprehensive QA for Radiation Oncology: report of the AAPM Radiation Therapy Committee Task Group No.40. Med Phys. 1994;21:581–618.CrossRefPubMed Kutcher GJ, Coia L, Gillin M, Hanson WF, Leibel S, Morton RJ, et al. Comprehensive QA for Radiation Oncology: report of the AAPM Radiation Therapy Committee Task Group No.40. Med Phys. 1994;21:581–618.CrossRefPubMed
11.
go back to reference Klein EE, Hanley J, Bayouth J, Yin FF, Simon W, Dresser S, et al. Task Group No. 142 report: quality assurance of medical accelerators. Med Phys. 2009;36:4197–212.CrossRefPubMed Klein EE, Hanley J, Bayouth J, Yin FF, Simon W, Dresser S, et al. Task Group No. 142 report: quality assurance of medical accelerators. Med Phys. 2009;36:4197–212.CrossRefPubMed
12.
go back to reference Ortiz Lopez P, Cosset JM, Dunscombe P, Holmberg O, Rosenwald JC, Pinillos Ashton L, et al. ICRP publication 112. A report of preventing accidental exposures from new external beam radiation therapy technologies. Ann. ICRP. 2009;39:1–86.PubMed Ortiz Lopez P, Cosset JM, Dunscombe P, Holmberg O, Rosenwald JC, Pinillos Ashton L, et al. ICRP publication 112. A report of preventing accidental exposures from new external beam radiation therapy technologies. Ann. ICRP. 2009;39:1–86.PubMed
13.
go back to reference Huq MS, Fraass BA, Dunscombe PB, Gibbons JP, Ibbott GS, Mundt AJ, et al. The report of Task Group 100 of the AAPM: application of risk analysis methods to radiation therapy quality management. Med Phys. 2016;43:4209–62.CrossRefPubMedPubMedCentral Huq MS, Fraass BA, Dunscombe PB, Gibbons JP, Ibbott GS, Mundt AJ, et al. The report of Task Group 100 of the AAPM: application of risk analysis methods to radiation therapy quality management. Med Phys. 2016;43:4209–62.CrossRefPubMedPubMedCentral
14.
go back to reference Malicki J, Przybylska K, Jahnen A, Godet JL, Valero M, Bulot M, et al. Radiation Protection nº181: General guidelines on risk management in external beam radiotherapy. European Commission 181; 2015. Malicki J, Przybylska K, Jahnen A, Godet JL, Valero M, Bulot M, et al. Radiation Protection nº181: General guidelines on risk management in external beam radiotherapy. European Commission 181; 2015.
15.
go back to reference Ford EC, Gaudette R, Myers L, Vanderver B, Engineer L, Zellars R, et al. Evaluation of safety in a radiation oncology setting using failure mode and effects analysis. J. Radiat Oncol Biol Phys. 2009;74:852–8.CrossRef Ford EC, Gaudette R, Myers L, Vanderver B, Engineer L, Zellars R, et al. Evaluation of safety in a radiation oncology setting using failure mode and effects analysis. J. Radiat Oncol Biol Phys. 2009;74:852–8.CrossRef
16.
go back to reference Teixeira FC, de Almeida CE, Huq MS. Failure mode and effects analysis based risk profile assessment for stereotactic radiosurgery programs at three cancer centers in Brazil. Med Phys. 2016;43:171–8.CrossRefPubMed Teixeira FC, de Almeida CE, Huq MS. Failure mode and effects analysis based risk profile assessment for stereotactic radiosurgery programs at three cancer centers in Brazil. Med Phys. 2016;43:171–8.CrossRefPubMed
17.
go back to reference Ibanez-Rosello B, Bautista-Ballesteros JA, Bonaque J, Celada F, Lliso F, Carmona V, et al. Failure mode and effects analysis of skin electronic brachytherapy using Esteya® unit. J Contemp Brachytherapy. 2016;8:518–24.CrossRefPubMedPubMedCentral Ibanez-Rosello B, Bautista-Ballesteros JA, Bonaque J, Celada F, Lliso F, Carmona V, et al. Failure mode and effects analysis of skin electronic brachytherapy using Esteya® unit. J Contemp Brachytherapy. 2016;8:518–24.CrossRefPubMedPubMedCentral
18.
go back to reference Yang F, Cao N, Young L, Howard J, Logan W, Arbuckle T, et al. Validating FMEA output against incident learning data: a study in stereotactic body radiation therapy. Med Phys. 2015;42:2777–85.CrossRefPubMed Yang F, Cao N, Young L, Howard J, Logan W, Arbuckle T, et al. Validating FMEA output against incident learning data: a study in stereotactic body radiation therapy. Med Phys. 2015;42:2777–85.CrossRefPubMed
19.
go back to reference Mayadev J, Dieterich S, Harse R, Lentz S, Mathai M, Boddu S, et al. A failure modes and effects analysis study for gynecologic high-dose-rate brachytherapy. Brachytherapy. 2015;14:866–75.CrossRefPubMed Mayadev J, Dieterich S, Harse R, Lentz S, Mathai M, Boddu S, et al. A failure modes and effects analysis study for gynecologic high-dose-rate brachytherapy. Brachytherapy. 2015;14:866–75.CrossRefPubMed
20.
go back to reference Sayler E, Eldredge-Hindy H, Dinome J, Lockamy V, Harrison AS. Clinical implementation and failure mode and effects analysis of HDR skin brachytherapy using Valencia and Leipzig surface applicators. Brachytherapy. 2014;14:293–9.CrossRefPubMed Sayler E, Eldredge-Hindy H, Dinome J, Lockamy V, Harrison AS. Clinical implementation and failure mode and effects analysis of HDR skin brachytherapy using Valencia and Leipzig surface applicators. Brachytherapy. 2014;14:293–9.CrossRefPubMed
21.
go back to reference Manger RP, Paxton AB, Pawlicki T, Kim GY. Failure mode and effects analysis and fault tree analysis of surface image guided cranial radiosurgery. Med Phys. 2015;42:2449–61.CrossRefPubMed Manger RP, Paxton AB, Pawlicki T, Kim GY. Failure mode and effects analysis and fault tree analysis of surface image guided cranial radiosurgery. Med Phys. 2015;42:2449–61.CrossRefPubMed
22.
go back to reference Younge KC, Wang Y, Thompson J, Giovinazzo J, Finlay M, Sankreacha R. Practical implementation of failure mode and effects analysis for safety and efficiency in stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2015;91:1003–8.CrossRefPubMed Younge KC, Wang Y, Thompson J, Giovinazzo J, Finlay M, Sankreacha R. Practical implementation of failure mode and effects analysis for safety and efficiency in stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2015;91:1003–8.CrossRefPubMed
23.
go back to reference López-Tarjuelo J, Bouché-Babiloni A, Santos-Serra A, Morillo-Macías V, Calvo FA, Kubyshin Y, et al. Failure mode and effect analysis oriented to risk-reduction interventions in intraoperative electron radiation therapy: the specific impact of patient transportation, automation, and treatment planning availability. Radiother Oncol. 2014;113:283–9.CrossRefPubMed López-Tarjuelo J, Bouché-Babiloni A, Santos-Serra A, Morillo-Macías V, Calvo FA, Kubyshin Y, et al. Failure mode and effect analysis oriented to risk-reduction interventions in intraoperative electron radiation therapy: the specific impact of patient transportation, automation, and treatment planning availability. Radiother Oncol. 2014;113:283–9.CrossRefPubMed
24.
go back to reference Masini L, Donis L, Loi G, Mones E, Molina E, Bolchini C, et al. Application of failure mode and effects analysis to intracranial stereotactic radiation surgery by linear accelerator. Pract Radiat Oncol. 2014;4:392–7.CrossRefPubMed Masini L, Donis L, Loi G, Mones E, Molina E, Bolchini C, et al. Application of failure mode and effects analysis to intracranial stereotactic radiation surgery by linear accelerator. Pract Radiat Oncol. 2014;4:392–7.CrossRefPubMed
25.
go back to reference Broggi S, Cantone MC, Chiara A, Di Muzio N, Longobardi B, Mangili P, et al. Application of failure mode and effects analysis (FMEA) to pretreatment phases in tomotherapy. J Appl Clin Med Phys. 2013;14:265–77.CrossRefPubMed Broggi S, Cantone MC, Chiara A, Di Muzio N, Longobardi B, Mangili P, et al. Application of failure mode and effects analysis (FMEA) to pretreatment phases in tomotherapy. J Appl Clin Med Phys. 2013;14:265–77.CrossRefPubMed
26.
go back to reference Cantone MC, Ciocca M, Dionisi F, Fossati P, Lorentini S, Krengli M, et al. Application of failure mode and effects analysis to treatment planning in scanned proton beam radiotherapy. Radiat Oncol. 2013;8:127.CrossRefPubMedPubMedCentral Cantone MC, Ciocca M, Dionisi F, Fossati P, Lorentini S, Krengli M, et al. Application of failure mode and effects analysis to treatment planning in scanned proton beam radiotherapy. Radiat Oncol. 2013;8:127.CrossRefPubMedPubMedCentral
27.
go back to reference Perks JR, Stanic S, Stern RL, Henk B, Nelson MS, Harse RD, et al. Failure mode and effect analysis for delivery of lung stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2012;83:1324–9.CrossRefPubMed Perks JR, Stanic S, Stern RL, Henk B, Nelson MS, Harse RD, et al. Failure mode and effect analysis for delivery of lung stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2012;83:1324–9.CrossRefPubMed
Metadata
Title
Failure modes and effects analysis of total skin electron irradiation technique
Authors
B. Ibanez-Rosello
J. A. Bautista
J. Bonaque
J. Perez-Calatayud
A. Gonzalez-Sanchis
J. Lopez-Torrecilla
L. Brualla-Gonzalez
T. Garcia-Hernandez
A. Vicedo-Gonzalez
D. Granero
A. Serrano
B. Borderia
C. Solera
J. Rosello
Publication date
01-03-2018
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 3/2018
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-017-1721-3

Other articles of this Issue 3/2018

Clinical and Translational Oncology 3/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine